J. Hagan Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$965K Buy
834
+4
+0.5% +$4.72K 0.43% 36
2026
Q2
$995K Buy
830
+28
+3% +$28.6K 0.46% 34
2026
Q1
$737K Buy
802
+43
+6% +$43.6K 0.4% 37
2025
Q4
$816K Buy
759
+34
+5% +$32.5K 0.45% 39
2025
Q3
$553K Buy
725
+69
+11% +$51.3K 0.34% 49
2025
Q2
$500K Sell
656
-49
-7% -$38.1K 0.34% 52
2025
Q1
$544K Buy
+705
New +$587K 0.44% 33

Other funds holding LLY

J. Hagan Capital's LLY Position: Q3 2026 in Review

J. Hagan Capital increased its Eli Lilly (LLY) stake by 0.48% in Q3 2026, buying an estimated $4.72K and bringing the position to 834 shares worth $965K. The position accounts for 0.43% of the portfolio, ranked #36.

J. Hagan Capital first reported a position in LLY in Q1 2025 and has held it in 7 quarters since. The position peaked at $995K in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • J. Hagan Capital held 834 shares of Eli Lilly worth $965K as of Q3 2026.
  • J. Hagan Capital bought 4 Eli Lilly shares in Q3 2026, an estimated $4.72K.
  • Eli Lilly made up 0.43% of J. Hagan Capital's portfolio in Q3 2026, its #36 holding.
  • J. Hagan Capital first reported a position in Eli Lilly in Q1 2025 and has held it in 7 quarters since.
  • J. Hagan Capital's Eli Lilly position peaked at $995K in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on J. Hagan Capital's 13F filing for Q3 2026, filed 13 Nov 2026.